EyePoint Pharmaceuticals, Inc.’s US$115 Million Public Offering Of Common Stock

Hogan Lovells has advised EyePoint Pharmaceuticals, Inc. on the deal.Cowen and Guggenheim Securities acted as joint book-running managers for the offering. Among other uses, this capital…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here